Evidence map›Paper›PMID 22147912›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2011

IgA and IgG antineutrophil cytoplasmic antibody engagement of Fc receptor genetic variants influences granulomatosis with polyangiitis.

James M Kelley, Paul A Monach, Chuanyi Ji, Yebin Zhou, Jianming Wu, Sumiaki Tanaka, Alfred D Mahr, Sharleen Johnson, Carol McAlear, David Cuthbertson and 15 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 84 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Observational
  14. IgA vasculitis.Seminars in immunopathology · 2021
    Review
  15. Article
  16. Article
  17. Review
  18. Observational
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors at 15 institutions in 4 countries.

James M KelleyDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Paul A Monach
Chuanyi Ji
Yebin Zhou
Jianming Wu
Sumiaki Tanaka
Alfred D Mahr
Sharleen Johnson
Carol McAlear
David Cuthbertson
Simon Carette
John C Davis
Paul F Dellaripa
Gary S Hoffman
Nader Khalidi
Carol A Langford
Phillip Seo
E William St Clair
Ulrich Specks
John H Stone
Robert F Spiera
Steven R Ytterberg
Peter A Merkel
Jeffrey C Edberg
Robert P Kimberly
University of Alabama at Birmingham · USBoston University · USCleveland Clinic · USMayo Clinic in Arizona · USBrigham and Women's Hospital · USDuke University · USHarvard University Press · USHôpital Saint-Louis · FRJohns Hopkins University · USMassachusetts General Hospital · USMcMaster University · CAMount Sinai Beth Israel · USUniversity of California, San Francisco · USUniversity of South Florida · USUniversity of Toronto · CA

Funding

Zevalin Radioimmunotherapy Using a Modified TreatmentM01RR000032 · NCRR · UNIVERSITY OF SOUTHERN CALIFORNIA · PI RICH, ROBERT R. · 1985 to 2008
$23.6M
UAB CENTER FOR CLINICAL AND TRANSLATIONAL SCIENCE (CCTS) UL1: BPCAUL1RR025777 · NCRR · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI GUAY-WOODFORD, LISA MARIE · 2008 to 2011
$22.3M
VCRC-VF FellowshipU54AR057319 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI MERKEL, PETER A · 2009 to 2020
$12.5M
Sex Related Determinants Of Pain In FibromyalgiaP60AR048095 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ARNETT, DONNA K · 2002 to 2012
$11.7M
ROS Modulation of Innate and Adaptive Immunity in RAP30AR048311 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI MOUNTZ, JOHN D · 2001 to 2017
$9.5M
VASCULITIS CLINICAL RESEARCH NETWORK (VCRN): RARE DISEASEU54RR019497 · NCRR · BOSTON UNIVERSITY MEDICAL CAMPUS · PI MERKEL, PETER A · 2003 to 2008
$6.1M
MONONUCLEAR PHAGOCYTE FUNCTION IN IMMUNOLOGIC DISEASESR01AR033062 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KIMBERLY, ROBERT P. · 1986 to 2010
$3.8M
TRAINING PROGRAM IN RHEUMATIC DISEASES RESEARCHT32AR007450 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BRIDGES, S LOUIS · 1986 to 2011
$2.2M
Genetic Polymorphisms in Wegener's GranulomatosisR01AR047799 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI EDBERG, JEFFREY C. · 2000 to 2003
$1.2M
NCRR NIH HHS 5UL1RR025777NCRR NIH HHS M01 RR000032NCRR NIH HHS M01-RR00032NCRR NIH HHS U54 RR019497NCRR NIH HHS UL1 RR025777NIAMS NIH HHS P30 AR048311NIAMS NIH HHS P30-AR48311NIAMS NIH HHS P60 AR048095NIAMS NIH HHS P60-AR48095NIAMS NIH HHS R01 AR033062NIAMS NIH HHS R01 AR047799NIAMS NIH HHS R01-AR33062NIAMS NIH HHS R01-AR47799NIAMS NIH HHS T32 AR007450NIAMS NIH HHS T32-AR07450NIAMS NIH HHS U54 AR057319NIAMS NIH HHS U54AR057319
6 · The paper itself

Abstract

Granulomatosis with polyangiitis (Wegener's) is a rare autoimmune neutrophil-mediated vasculitis that can cause renal disease and mucosal manifestations. Antineutrophil cytoplasmic antibodies (ANCA) are present in many patients, vary in level over time, and induce neutrophil activation through engagement with Fc receptors (FcRs). Given roles for FcRs in ANCA-mediated neutrophil activation and IgA antibodies in mucosal immunity, we hypothesized that FcR genetics and previously unappreciated IgA ANCA affect clinical presentation. We assembled a total of 673 patients and 413 controls from two multicenter cohorts, performed ELISA and immunofluorescence assays to determine IgA and IgG ANCA positivity, and used Illumina, TaqMan, or Pyrosequencing to genotype eight haplotype-tagging SNPs in the IgA FcR (FCAR) and to determine NA1/NA2 genotype of FCGR3B, the most prevalent neutrophil IgG FcR. We evaluated neutrophil activation by measuring degranulation marker CD11b with flow cytometry or neutrophil extracellcular trap formation with confocal microscopy. Functional polymorphisms in FCGR3B and FCAR differed between patient groups stratified by renal involvement. IgA ANCA were found in ∼30% of patients and were less common in patients with severe renal disease. Neutrophil stimulation by IgA or IgG ANCA led to degranulation and neutrophil extracellcular trap formation in a FcR allele-specific manner (IgA:FCAR P = 0.008; IgG:FCGR3B P = 0.003). When stimulated with IgA and IgG ANCA together, IgG ANCA induced neutrophil activation was reduced (P = 0.0001). FcR genotypes, IgA ANCA, and IgG ANCA are potential prognostic and therapeutic targets for understanding the pathogenesis and presentation of granulomatosis with polyangiitis (Wegener's).

Indexed as

Genetic VariationAllelesAntibodies, Antineutrophil CytoplasmicCase-Control StudiesCohort StudiesCross-Sectional StudiesFemaleGenomicsGranulomatosis with PolyangiitisHumansImmunoglobulin AImmunoglobulin GInflammationKidney DiseasesMaleMicroscopy, FluorescenceAntibodies, Antineutrophil CytoplasmicImmunoglobulin AImmunoglobulin GReceptors, Fc

Identifiers

PMID22147912
PMCPMC3251158
OpenAlexW1979530683

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.